
Founded in 2000, Hospital CIMA San José is a leading private healthcare institution known for its excellence in patient care, advanced medical technology, and highly specialized doctors. The hospital provides a wide range of medical services, including cardiology, oncology, neurology, orthopedics, urology, and reconstructive surgery. With a strong focus on innovation, research, and patient-centered care, CIMA San José is committed to delivering world-class healthcare solutions.
Advanced Technology & Facilities
Key Services at Hospital CIMA San José
Hospital CIMA San José is a benchmark for excellence in private healthcare, combining medical advancements, top specialists, and a commitment to compassionate, patient-centered care, making it a preferred choice for patients worldwide.

Established in 1929, Hospital Clinica Biblica has grown from a modest clinic into one of Costa Rica’s leading medical institutions. With over 90 years of excellence, the hospital is recognized for its commitment to world-class healthcare, advanced medical technology, and compassionate patient care. As a Joint Commission International (JCI)-accredited hospital, Clinica Biblica upholds the highest standards in patient safety and medical excellence, attracting patients from around the world.
Advanced Technology & Facilities
Key Services

Hospital La Católica Costa Rica, established on March 16, 1963, is a leading private healthcare provider in Costa Rica. Founded by a group of Franciscan sisters and dedicated physicians, the hospital has upheld a strong commitment to patient well-being for decades. It has built a solid reputation for offering high-quality, personalized medical services, making it a trusted name in the country's healthcare sector.
Key Features of Hospital La Católica Costa Rica?
Through a patient-centered approach and commitment to continuous progress, Hospital La Católica Costa Rica remains a top choice for both local and international patients seeking quality healthcare in Costa Rica. With its dedication to excellence, expanding specialties, and modern medical solutions, the hospital continues to be a leading private healthcare provider in Costa Rica.

Onco-hematology focuses on the diagnosis and treatment of cancers affecting the blood, bone marrow, and lymphatic system, as well as solid tumors requiring systemic therapies. According to the World Health Organization (WHO), cancer remains one of the leading global health challenges, and the demand for structured, evidence-based oncology services continues to grow. In recent years, Costa Rica has modernized its oncology and hematology infrastructure, integrating molecular diagnostics, immunotherapy protocols, targeted therapies, digital pathology systems, and multidisciplinary tumor boards into routine clinical practice. These developments occur within a nationally regulated healthcare framework designed to promote patient safety, professional accountability, and institutional oversight.
Costa Rica’s healthcare system operates under the supervision of the Ministry of Health (Ministerio de Salud de Costa Rica), with public services administered through the Caja Costarricense de Seguro Social (CCSS). Both public and private institutions must comply with licensing regulations, safety inspections, radiation control standards, pharmaceutical governance, and professional credentialing requirements. Physicians specializing in onco-hematology complete an accredited medical degree followed by residency training in internal medicine and subsequent subspecialty fellowship in medical oncology, hematology, or hemato-oncology. Board certification and registration with the national medical college are mandatory. Continuous professional development through Continuing Medical Education (CME), academic congress participation, and peer-review processes forms part of maintaining licensure and alignment with international clinical governance principles.
Modern hospitals in Costa Rica offering onco-hematology services are equipped with advanced infusion centers, sterile chemotherapy preparation units, diagnostic imaging departments (including CT, MRI, PET-CT in selected centers), pathology laboratories with immunohistochemistry capabilities, and blood bank services. Tertiary-care hospitals provide access to intensive care units, surgical oncology collaboration, and multidisciplinary tumor boards that review complex cases. Several institutions maintain academic affiliations with national universities, supporting specialist training and research initiatives. Clinical governance emphasizes structured chemotherapy safety protocols, medication verification systems, infection prevention standards, and formal consent procedures consistent with international oncology guidelines.
For international patients considering onco-hematology treatment in Costa Rica, the process typically begins with gathering medical documentation. In practice, hospitals commonly request pathology reports, biopsy results, imaging studies, prior treatment summaries, laboratory values, and medication histories before offering a preliminary review. Communication with international patient departments often occurs via secure digital platforms or scheduled video consultations. Administrative teams commonly clarify documentation requirements, estimated timelines, and institutional processes. Many visitors from North America and Europe can enter Costa Rica for short stays without complex visa procedures, though requirements depend on nationality. The expected duration of stay varies according to treatment type-patients undergoing systemic therapy cycles may require several weeks of coordinated planning. English-speaking staff are often available in private institutions, and interpretation services are frequently arranged when necessary. After returning home, patients are typically advised to coordinate follow-up care with their local oncologist or hematologist to maintain continuity of monitoring and laboratory evaluation.
Families commonly ask practical questions regarding chemotherapy safety standards, infection control measures for immunocompromised patients, blood product availability, pharmacy protocols, and how medical records are shared internationally. These questions reflect understandable concerns about safety and transparency within oncology care and are routinely addressed during pre-treatment coordination.
Onco-hematology services in Costa Rica incorporate contemporary diagnostic and therapeutic approaches aligned with international oncology standards. Molecular pathology, immunohistochemistry, and genetic testing increasingly inform personalized treatment planning. Targeted therapies and immunotherapies are integrated into systemic treatment regimens when clinically indicated. Digital imaging technologies, including high-resolution CT, MRI, and PET-CT (in selected centers), support staging accuracy and treatment monitoring.
Strict protocols govern chemotherapy preparation and administration. Oncology pharmacies utilize sterile compounding facilities, double-verification systems, and medication traceability documentation to reduce error risk. Radiation safety protocols apply to imaging and radiotherapy services. Anesthesia teams support procedural interventions such as biopsies or central line placements under structured monitoring standards. Infection prevention measures are particularly emphasized in hematology units, where patients may have compromised immune systems. Post-treatment monitoring includes laboratory tracking, infusion center observation, and structured follow-up scheduling.
Continuous professional education is central to oncology practice. Specialists regularly attend international oncology conferences and participate in CME programs to remain aligned with evolving evidence-based standards. Treatment plans are individualized following multidisciplinary case discussions and comprehensive diagnostic review. Informed consent is required before initiating systemic therapy or invasive procedures, and final clinical decisions depend exclusively on licensed medical evaluation. At a national level, Costa Rica continues to strengthen oncology governance through regulated oversight and institutional accountability.
Chemotherapy (Systemic Therapy)
Chemotherapy involves the administration of cytotoxic medications designed to target rapidly dividing cancer cells. Treatment planning typically relies on pathology reports, imaging studies, and laboratory evaluation. Medications are prepared in sterile pharmacy units and administered in dedicated infusion centers under nursing supervision. Safety protocols include dose verification, infusion monitoring, and supportive medication management. The objective is systemic disease control within a structured safety framework.
Immunotherapy
Immunotherapy utilizes medications that stimulate or modulate the body’s immune system to recognize and respond to cancer cells. Diagnostic evaluation often includes molecular or biomarker testing to guide eligibility assessment. Administration occurs in infusion centers under medical supervision with monitoring for immune-related reactions. Institutional oversight ensures adherence to pharmaceutical safety standards and documentation practices.
Targeted Therapy
Targeted therapies focus on specific molecular pathways involved in cancer growth. Molecular diagnostics, including genetic or protein expression analysis, guide treatment planning. These therapies may be administered orally or intravenously. Monitoring protocols include laboratory tests and imaging assessments to evaluate therapeutic response and safety parameters.
Bone Marrow and Hematologic Disorder Management
Onco-hematology specialists manage conditions such as leukemia, lymphoma, multiple myeloma, and other blood disorders. Diagnostic workflows often include bone marrow biopsy, flow cytometry, cytogenetic testing, and imaging studies. Treatment may involve systemic therapy, transfusion support, or coordination with transplant centers when indicated. Infection prevention protocols and hematologic monitoring are central to patient safety.
Radiation Oncology Collaboration
While radiation therapy may be delivered by specialized departments, onco-hematologists collaborate closely with radiation oncologists in multidisciplinary treatment planning. Imaging-based planning systems and radiation safety standards govern procedural accuracy. Multidisciplinary tumor boards support coordinated decision-making.
Supportive and Palliative Oncology Care
Supportive care services address symptom management, nutritional assessment, and psychosocial support during cancer treatment. Clinical oversight ensures appropriate medication management and documentation. The objective is to maintain patient stability and comfort within an evidence-based care framework.
Hospital CIMA San José
Accreditations:
Joint Commission International (JCI)
Licensed and regulated by the Ministry of Health of Costa Rica
Specializations:
Provides comprehensive oncology services including medical oncology, hematology, infusion therapy, and multidisciplinary tumor boards supported by advanced imaging and pharmacy services.
Clínica Bíblica Hospital
Accreditations:
Joint Commission International (JCI)
Regulated by the Ministry of Health
Specializations:
Offers oncology diagnostics, chemotherapy infusion units, and collaboration with surgical and radiation oncology departments within a structured clinical governance framework.
Hospital México (CCSS)
Accreditations:
Public tertiary-care hospital under CCSS
Ministry of Health oversight
Specializations:
Major public referral center for hematology and oncology, providing multidisciplinary cancer management, academic training programs, and laboratory diagnostic services.
Hospital San Juan de Dios (CCSS)
Accreditations:
Public hospital regulated by CCSS
Ministry of Health oversight
Specializations:
Offers oncology and hematology services within a university-affiliated environment, supporting complex case management and specialist training.
Hospital Calderón Guardia (CCSS)
Accreditations:
Public tertiary-care institution under CCSS
Regulated by the Ministry of Health
Specializations:
Provides oncology diagnostics, systemic therapy services, and collaborative surgical oncology programs supported by ICU capacity.
Hospital Metropolitano
Accreditations:
Licensed by the Ministry of Health
Private regulated institution
Specializations:
Provides oncology consultations, infusion therapy, and diagnostic imaging services within a private hospital setting under national regulatory oversight.
| Procedure | Estimated Cost Range (USD) |
| Chemotherapy Cycle | $2,000-$6,000 |
| Immunotherapy Session | $3,000-$8,000 |
| Targeted Therapy (Monthly) | $2,500-$7,500 |
| Bone Marrow Biopsy | $1,000-$2,500 |
| PET-CT Scan | $1,500-$3,000 |
| Oncology Consultation | $150-$400 |
Note: The prices listed above are approximate, non-binding estimates provided for general informational purposes only. Actual treatment costs may vary based on individual clinical requirements, diagnostic findings, treatment complexity, materials or technology used, physician expertise, facility type, and duration of care. Final pricing is determined only after a professional evaluation by a licensed specialist or accredited medical institution.
Costa Rica’s oncology services operate within a nationally regulated healthcare framework emphasizing institutional accountability and patient safety. The Ministry of Health oversees hospital licensing, radiation safety standards, pharmaceutical governance, and professional certification. Public and private oncology centers adhere to documented chemotherapy preparation protocols, multidisciplinary case review processes, and infection control standards.
Specialist training pathways include formal residency and fellowship programs with mandatory professional registration. Continuous medical education and participation in international oncology networks support evidence-based practice. Hospitals commonly maintain electronic medical record systems and provide structured documentation for continuity of care.
Costa Rica has also implemented medical tourism frameworks promoting ethical practice, transparency, and patient protection. International patient departments frequently assist with document review, scheduling coordination, and communication with referring physicians.
Restrictions and Practical Considerations
Eligibility for oncology treatment depends on clinical evaluation, staging, and prior treatment history. Some therapies may require prolonged stays or coordination across multiple treatment cycles. Travel planning should consider immune status, recovery needs, and follow-up care arrangements. Coordination with a home-country oncologist is typically encouraged to ensure continuity of laboratory monitoring and imaging.
Choosing cancer treatment abroad can understandably feel overwhelming. National oversight, licensed specialists, structured pharmacy controls, and institutional governance frameworks are designed to provide reassurance that care is delivered within a regulated and accountable healthcare system.
Best Clinic Abroad is a medical travel facilitator that supports individuals exploring onco-hematology treatment options internationally. It is not a medical provider, does not offer diagnosis, and does not influence clinical decisions. Its role is limited to non-clinical coordination and administrative guidance.
➤ Hospital coordination - Support communication and coordination with accredited hospitals
➤ Appointment support - Assist with scheduling and organizing consultations
➤ Communication assistance - Help patients understand next steps without replacing medical advice
➤ Logistical guidance - Offer non-clinical support related to travel planning
All medical decisions are made exclusively by licensed physicians and accredited hospitals, and you may reach out if you would like assistance organizing communication with regulated oncology institutions in Costa Rica.
Where is the best medical care in Costa Rica?
Costa Rica provides medical care through public hospitals under the CCSS and regulated private institutions licensed by the Ministry of Health. Some private hospitals hold international accreditations such as JCI, while public tertiary-care hospitals provide specialized services within structured governance systems. The most appropriate facility for you depends on clinical needs and professional evaluation.
What is the cancer rate in Costa Rica?
Cancer incidence in Costa Rica is monitored through national health registries and public health reporting systems. Like many countries, Costa Rica experiences a range of cancer types influenced by age distribution, lifestyle factors, and screening programs. Public health initiatives focus on prevention, early detection, and access to structured oncology services.
Is Costa Rica a healthy country?
Costa Rica is often recognized for strong public health indicators in Latin America, including life expectancy and access to healthcare services. The country maintains a regulated healthcare system under Ministry of Health oversight, with structured public and private services. As with any country, health outcomes vary based on individual factors and access to medical care.
Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. It reflects non-clinical observation of healthcare coordination processes and institutional practices in Costa Rica and does not represent direct medical practice. Diagnosis and treatment decisions should always be made in consultation with a licensed medical specialist based on individual clinical evaluation.
Last updated: February 2026

